HSHHSH Health Technology Supplier Hub

Suppliers starting with “B”

Showing 1–16 of 16

B. BraunHQ Germany · Europe
Medical devices & monitoring

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
BaxterHQ United States · North America
Medical devices & monitoring

FY2025 revenue $11.24bn (+5.7%); operating margin -2.7%; net loss $957.0m.

Continuing operations; operating loss after impairment and restructuring charges.

Financial health: WeakRisk summary →
No reviews yet
View profile
BD (Becton, Dickinson and Company)HQ United States · North America
Diagnostics & IVDMedical devices & monitoringPharmacy & medicines management

FY2026 revenue $19.46bn (+4.9%); operating margin 11.6%; net income $1.15bn.

Continuing operations; net income from continuing operations $1.42bn (+29%).

Financial health: StrongRisk summary →
No reviews yet
View profile
Beckman CoulterHQ United States · North America
Diagnostics & IVDLaboratory & pathology (LIMS)

Parent Danaher (DHR) group FY2025 revenue $24.57bn (+3.0%); operating margin 19.1%; net income $3.60bn.

Figures cover the whole listed group, not this business alone.

Financial health: StrongRisk summary →
No reviews yet
View profile
Best Practice SoftwareHQ Australia · Asia-Pacific
Primary care systems

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
BetterHQ Slovenia · Europe
Electronic health records (EHR/EPR)Interoperability & integration

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
BGI GenomicsHQ China · Asia-Pacific
Genomics & precision medicine

Listed (300676.SZ).

Latest full-year results not yet captured by HSH.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
Big HealthHQ United States · North America
Digital therapeutics & appsMental health, community & social care

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
Bio-Rad LaboratoriesHQ United States · North America
Diagnostics & IVDLaboratory & pathology (LIMS)

FY2025 revenue $2.58bn (+0.7%); operating margin 1.8%; net income $759.9m.

Net income lifted by non-operating investment gains; operating profit was $47m.

Financial health: FairRisk summary →
No reviews yet
View profile
BiofourmisHQ United States · North America
Remote monitoring & virtual wards

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
bioMérieuxHQ France · Europe
Diagnostics & IVD

FY2025 revenue €4.07bn (+2.3%); contributive operating margin (CEBIT) 17.9%; net income €398.0m.

Balance sheet figures not captured from release.

Financial health: StrongRisk summary →
No reviews yet
View profile
BiotronikHQ Germany · Europe
Medical devices & monitoringRemote monitoring & virtual wards

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
Black Pear SoftwareHQ United Kingdom · Europe
Interoperability & integration

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
Boston ScientificHQ United States · North America
Medical devices & monitoring

FY2025 revenue $20.07bn (+19.9%); operating margin 18.0%; net income $2.90bn.

Balance sheet figures not captured from release.

Financial health: StrongRisk summary →
No reviews yet
View profile
BrainlabHQ Germany · Europe
Imaging, PACS & RISSurgical & theatre systems

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
BrainomixHQ United Kingdom · Europe
Clinical AI & decision supportImaging, PACS & RIS

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile